GirishNadkarni Icahn School of Medicine at Mount Sinai and the Mount Sinai Health SystemUnited States

Dr. Girish N. Nadkarni is a physician-scientist and clinical informaticist, whose career is marked by leadership in artificial intelligence (AI) and precision medicine. He is currently the Fishberg Professor of Medicine, the Director of the Charles Bronfman Institute for Personalized Medicine and the Inaugural System Chief of the Division of Data-Driven and Digital Medicine at the Icahn School of Medicine at Mount Sinai. He has spearheaded transformative and translational research leading to 349 original peer-reviewed research and 52 invited publications with over 37,000 citations and an h-index of 86. These include senior authored papers in journals including Journal of American Medical Association, Annals of Internal Medicine, Journal of American College of Cardiology and Lancet Digital Health. His work has advanced fields including precision cardiovascular and kidney care, including landmark studies using electrocardiograms for predicting outcomes, understanding impact of predictive AI in healthcare, AI-bioprognostics for kidney disease and several studies on APOL1 genetic risk for kidney disease. Dr. Nadkarni's innovations extend to entrepreneurship, where he co-founded several companies that have pioneered AI-based approaches, with some receiving FDA clearance. He is principal investigator for seven concurrent R01 grants or equivalents, three industry contracts and two NIH contracts for a cumulative amount of ~$40 million. Additionally, he holds numerous patents on AI and predictive applications in healthcare and co-invented the first FDA approved AI-bioprognostic for kidney disease. His influence is reflected in external leadership roles, including Chair of the Taskforce on AI/Digital Health and Associate Editor of NPJ Digital Medicine. His mentorship has seen 14 of his mentees attain independent faculty roles, underscoring his commitment to fostering future leaders in medicine. He has received several honors including the ANIO rising star award, the Carl Nacht Memorial lecture and the Harold Lamport clinical research award.